761 related articles for article (PubMed ID: 33970243)
1. The Cryo-EM Effect: Structural Biology of Neurodegenerative Disease Aggregates.
Creekmore BC; Chang YW; Lee EB
J Neuropathol Exp Neurol; 2021 Jun; 80(6):514-529. PubMed ID: 33970243
[TBL] [Abstract][Full Text] [Related]
2. The Cryo-EM Effect: Structural Biology of Neurodegenerative Disease Proteostasis Factors.
Creekmore BC; Chang YW; Lee EB
J Neuropathol Exp Neurol; 2021 Jun; 80(6):494-513. PubMed ID: 33860329
[TBL] [Abstract][Full Text] [Related]
3. Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception.
Moda F; Ciullini A; Dellarole IL; Lombardo A; Campanella N; Bufano G; Cazzaniga FA; Giaccone G
Front Biosci (Landmark Ed); 2023 Oct; 28(10):255. PubMed ID: 37919089
[TBL] [Abstract][Full Text] [Related]
4. Emerging Trends in Cryo-EM-based Structural Studies of Neuropathological Amyloids.
Mishra S
J Mol Biol; 2023 Dec; 435(24):168361. PubMed ID: 37949311
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids.
Scheres SHW; Ryskeldi-Falcon B; Goedert M
Nature; 2023 Sep; 621(7980):701-710. PubMed ID: 37758888
[TBL] [Abstract][Full Text] [Related]
6. Cryo-EM structures of pathogenic fibrils and their impact on neurodegenerative disease research.
Todd TW; Islam NN; Cook CN; Caulfield TR; Petrucelli L
Neuron; 2024 May; ():. PubMed ID: 38834068
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases.
Lin WL; Dickson DW
Acta Neuropathol; 2008 Aug; 116(2):205-13. PubMed ID: 18607609
[TBL] [Abstract][Full Text] [Related]
8. Neurodegenerative Disease Tauopathies.
Creekmore BC; Watanabe R; Lee EB
Annu Rev Pathol; 2024 Jan; 19():345-370. PubMed ID: 37832941
[TBL] [Abstract][Full Text] [Related]
9. Structures of tau and α-synuclein filaments from brains of patients with neurodegenerative diseases.
Kametani F; Hasegawa M
Neurochem Int; 2022 Sep; 158():105362. PubMed ID: 35659527
[TBL] [Abstract][Full Text] [Related]
10. Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases.
Sengupta U; Kayed R
Prog Neurobiol; 2022 Jul; 214():102270. PubMed ID: 35447272
[TBL] [Abstract][Full Text] [Related]
11. [Pathology of basal ganglia in neurodegenerative diseases].
Wakabayashi K; Tanji K; Mori F
Brain Nerve; 2009 Apr; 61(4):429-39. PubMed ID: 19378813
[TBL] [Abstract][Full Text] [Related]
12. Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson's disease: ex vivo and in vitro studies.
Horvath I; Iashchishyn IA; Moskalenko RA; Wang C; Wärmländer SKTS; Wallin C; Gräslund A; Kovacs GG; Morozova-Roche LA
J Neuroinflammation; 2018 Jun; 15(1):172. PubMed ID: 29866153
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.
Jucker M; Walker LC
Ann Neurol; 2011 Oct; 70(4):532-40. PubMed ID: 22028219
[TBL] [Abstract][Full Text] [Related]
14. Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau
Stopschinski BE; Holmes BB; Miller GM; Manon VA; Vaquer-Alicea J; Prueitt WL; Hsieh-Wilson LC; Diamond MI
J Biol Chem; 2018 Jul; 293(27):10826-10840. PubMed ID: 29752409
[TBL] [Abstract][Full Text] [Related]
15. SGTA associates with intracellular aggregates in neurodegenerative diseases.
Kubota S; Doi H; Koyano S; Tanaka K; Komiya H; Katsumoto A; Ikeda S; Hashiguchi S; Nakamura H; Fukai R; Takahashi K; Kunii M; Tada M; Takeuchi H; Tanaka F
Mol Brain; 2021 Mar; 14(1):59. PubMed ID: 33757575
[TBL] [Abstract][Full Text] [Related]
16. Structural Identification of Individual Helical Amyloid Filaments by Integration of Cryo-Electron Microscopy-Derived Maps in Comparative Morphometric Atomic Force Microscopy Image Analysis.
Lutter L; Al-Hilaly YK; Serpell CJ; Tuite MF; Wischik CM; Serpell LC; Xue WF
J Mol Biol; 2022 Apr; 434(7):167466. PubMed ID: 35077765
[TBL] [Abstract][Full Text] [Related]
17. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
Goedert M
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
[TBL] [Abstract][Full Text] [Related]
18. Cellular and pathological heterogeneity of primary tauopathies.
Chung DC; Roemer S; Petrucelli L; Dickson DW
Mol Neurodegener; 2021 Aug; 16(1):57. PubMed ID: 34425874
[TBL] [Abstract][Full Text] [Related]
19. Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases.
Chang A; Xiang X; Wang J; Lee C; Arakhamia T; Simjanoska M; Wang C; Carlomagno Y; Zhang G; Dhingra S; Thierry M; Perneel J; Heeman B; Forgrave LM; DeTure M; DeMarco ML; Cook CN; Rademakers R; Dickson DW; Petrucelli L; Stowell MHB; Mackenzie IRA; Fitzpatrick AWP
Cell; 2022 Apr; 185(8):1346-1355.e15. PubMed ID: 35247328
[TBL] [Abstract][Full Text] [Related]
20. Tau filaments in neurodegenerative diseases.
Goedert M
FEBS Lett; 2018 Jul; 592(14):2383-2391. PubMed ID: 29790176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
